International Stem Cell Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISCO research report →
About the company
International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, and beyond. Central to its offerings are products derived from its proprietary human parthenogenetic stem cells, a unique form of pluripotent stem cells. ISCO is actively engaged in developing specialized cell types, such as neural stem cells, which hold promise for treating Parkinson's disease and other disorders affecting the central nervous system.
- CEO
- Andrey Semechkin
- IPO
- 2007
- Employees
- 32
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $1.60M
- P/E
- -4.40
- P/S
- 0.17
- P/B
- -0.38
- EV/EBITDA
- -95.18
- Div Yield
- 0.00%
- Gross Margin
- 56.98%
- Op Margin
- -2.61%
- Net Margin
- -4.11%
- ROE
- 9.58%
- ROIC
- -6.71%
- Revenue
- $9.10M · 0.17%
- Net Income
- $-418,000 · -100.00%
- EPS
- $-0.05 · -91.57%
- Op Income
- $-267,000
- FCF YoY
- 77.12%
- 52W High
- $0.27
- 52W Low
- $0.12
- 50D MA
- $0.17
- 200D MA
- $0.16
- Beta
- 0.07
- Avg Volume
- 2.50K
Get TickerSpark's AI analysis on ISCO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | Don Wright | other | 182,584 |
| Jun 11, 26 | Don Wright | other | 30,000 |
| Jun 11, 26 | MAIER PAUL V | other | 182,584 |
| Jun 11, 26 | MAIER PAUL V | other | 30,000 |
| Jun 17, 25 | Don Wright | other | 532,786 |
| Jun 17, 25 | Don Wright | other | 30,000 |
| Nov 6, 23 | Semechkin Andrey | other | 500,000 |
| Nov 6, 23 | Kern Russell | other | 2,000,000 |
| Jun 14, 23 | Don Wright | other | 445,205 |
| Jun 14, 23 | Don Wright | other | 30,000 |
Our ISCO coverage
Recent articles, reports, and earnings notes.
No research on ISCO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ISCO report →Similar companies
Peers in the same neighborhood.